Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 5/20 | 0.60 |
| ▸ | MAOB | P27338 | 2/20 | 0.58 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | SCN4A | P35499 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9685669 | 1.00 | BCHE (0.60) | BCHEMAOBACHESCN4A | |
| SCHEMBL2893650 | 1.00 | BCHE (0.60) | BCHEMAOBACHESCN4A | |
| SCHEMBL19038337 | 0.92 | BCHE (0.72) | BCHEMAOBACHE | |
| SCHEMBL4135213 | 0.91 | BCHE (0.67) | BCHEACHE | |
| Hydrochloric Acid SCHEMBL9380707 | 0.90 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL11478274 | 0.89 | BCHE (0.54) | BCHEMAOB | |
| SCHEMBL250507 | 0.88 | BCHE (0.61) | BCHEMAOB | |
| SCHEMBL7301577 | 0.87 | BCHE (0.57) | BCHEMAOBSCN4A | |
| SCHEMBL8915069 | 0.87 | BCHE (0.57) | BCHEMAOBSCN4A | |
| SCHEMBL27315592 | 0.86 | BCHE (0.61) | BCHEMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1113365-A | — | — | None | — | — | JP | disclosed |
| JP-5227991-A | — | — | None | — | — | JP | disclosed |
| CN-111808007-A | Preparation method of chiral 3-substituted pyrrolidine derivative | 青岛贞开生物医药技术有限公司 | 2020-10-23 | — | — | CN | disclosed |
| CN-108884068-A | 1- cyano-pyrolidin derivative as DUB inhibitor | 特殊治疗有限公司 | 2018-11-23 | — | — | CN | disclosed |
| US-8940782-B2 | Composition for repelling and deterring vermin | NOVARTIS AG (CH) | 2015-01-27 | — | — | US | disclosed |
| US-20130143924-A1 | COMPOSITION FOR REPELLING AND DETERRING VERMIN | ELANCO TIERGESUNDHEIT AG (CH) | 2013-06-06 | — | — | US | disclosed |
| US-8338490-B2 | Composition for repelling and deterring vermin | NOVARTIS AG (CH) | 2012-12-25 | — | — | US | disclosed |
| EP-2094079-B1 | COMPOSITION FOR REPELLING AND DETERRING VERMIN | NOVARTIS AG (CH) | 2012-11-14 | — | — | EP | disclosed |
| WO-2010049678-A2 | TREATMENT OF ENERGY UTILIZATION DISEASES | SUMMIT CORPORATION PLC (GB) | 2010-05-06 | — | — | WO | disclosed |
| US-20100063090-A1 | Composition for Repelling and Deterring Vermin | NOVARTIS AG (CH) | 2010-03-11 | — | — | US | disclosed |
| WO-2010015815-A2 | COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS | SUMMIT CORPORATION PLC (GB) | 2010-02-11 | — | — | WO | disclosed |
| EP-2094079-A1 | COMPOSITION FOR REPELLING AND DETERRING VERMIN | Novartis Ag (CH) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008062006-A1 | COMPOSITION FOR REPELLING AND DETERRING VERMIN | NOVARTIS AG (CH) | 2008-05-29 | — | — | WO | disclosed |
| EP-1114027-B1 | THE PREPARATION OF N-SUBSTITUTED-HYDROXYCYCLOALKYLAMINE DERIVATIVES | SAMSUNG FINE CHEMICALS CO LTD (KR) | 2003-06-04 | — | — | EP | disclosed |
| US-6566525-B1 | Reacting a 1,2-dihydroxalkyl alcohol with a thionyl halide to produce an intermediate 1,2-cyclosulfinylalkyl halide, and then cyclizing that intermediate with an amine compound | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2003-05-20 | — | — | US | disclosed |
| EP-1114027-A1 | THE PREPARATION OF N-SUBSTITUTED-HYDROXYCYCLOALKYLAMINE DERIVATIVES | Samsung Fine Chemicals Co., Ltd. (KR) | 2001-07-11 | — | — | EP | disclosed |
| WO-2000015610-A1 | THE PREPARATION OF N-SUBSTITUTED-HYDROXYCYCLOALKYLAMINE DERIVATIVES | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-03-23 | — | — | WO | disclosed |
| JP-H05227991-A | PRODUCTION OF OPTICALLY ACTIVE 3-PYRROLIDINOL DERIVATIVE | KYOWA HAKKO KOGYO CO LTD | 1993-09-07 | — | — | JP | disclosed |
| JP-H01113365-A | NOVEL PYRROLIDINE DERIVATIVE AND PRODUCTION THEREOF | KANEGAFUCHI CHEM IND CO LTD | 1989-05-02 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063090-A1 | Composition for Repelling and Deterring Vermin | AAAS, SERPINC1, FABP1 | BCHE 40/4885MAOB 990/4885ACHE 27/4885 |
| US-20130143924-A1 | COMPOSITION FOR REPELLING AND DETERRING VERMIN | ACHE, PNMT, AAAS | BCHE 5/4885MAOB 517/4885ACHE 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.